Vytrus Biotech (Spain) Probability of Future Stock Price Finishing Over 2.18

VYT Stock   2.18  0.04  1.80%   
Vytrus Biotech's future price is the expected price of Vytrus Biotech instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Vytrus Biotech SA performance during a given time horizon utilizing its historical volatility. Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
  
Please specify Vytrus Biotech's target price for which you would like Vytrus Biotech odds to be computed.

Vytrus Biotech Target Price Odds to finish over 2.18

The tendency of Vytrus Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 2.18 90 days 2.18 
about 78.36
Based on a normal probability distribution, the odds of Vytrus Biotech to move above the current price in 90 days from now is about 78.36 (This Vytrus Biotech SA probability density function shows the probability of Vytrus Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon Vytrus Biotech has a beta of 0.32. This entails as returns on the market go up, Vytrus Biotech average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Vytrus Biotech SA will be expected to be much smaller as well. Additionally Vytrus Biotech SA has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Vytrus Biotech Price Density   
       Price  

Predictive Modules for Vytrus Biotech

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Vytrus Biotech SA. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Vytrus Biotech Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Vytrus Biotech is not an exception. The market had few large corrections towards the Vytrus Biotech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Vytrus Biotech SA, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Vytrus Biotech within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.54
β
Beta against Dow Jones0.32
σ
Overall volatility
0.51
Ir
Information ratio -0.16

Vytrus Biotech Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Vytrus Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Vytrus Biotech SA can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Vytrus Biotech SA generated a negative expected return over the last 90 days
Vytrus Biotech SA has high historical volatility and very poor performance

Vytrus Biotech Technical Analysis

Vytrus Biotech's future price can be derived by breaking down and analyzing its technical indicators over time. Vytrus Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Vytrus Biotech SA. In general, you should focus on analyzing Vytrus Stock price patterns and their correlations with different microeconomic environments and drivers.

Vytrus Biotech Predictive Forecast Models

Vytrus Biotech's time-series forecasting models is one of many Vytrus Biotech's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Vytrus Biotech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Vytrus Biotech SA

Checking the ongoing alerts about Vytrus Biotech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Vytrus Biotech SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Vytrus Biotech SA generated a negative expected return over the last 90 days
Vytrus Biotech SA has high historical volatility and very poor performance